Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

9.3B
+3%
Assets
Growth Rates:
1 Year
+5%
3 Years
+105%
5 Years
+133%
7 Years
+188%
10 Years
+5 767%
4B
+2%
Liabilities
Growth Rates:
1 Year
+2%
3 Years
+83%
5 Years
+27%
7 Years
+111%
10 Years
+4 421%
5.3B
+4%
Equity
Growth Rates:
1 Year
+7%
3 Years
+125%
5 Years
+517%
7 Years
+297%
10 Years
+7 455%

Balance Sheet Decomposition
Horizon Therapeutics PLC

9.3B
Assets
4B
Liabilities
9.3B
Assets
4B
Liabilities
Current Assets 3.9B
Cash & Short-Term Investments 2.5B
Receivables 717.4m
Other Current Assets 739.9m
Non-Current Assets 5.4B
PP&E 504.2m
Intangibles 4.3B
Other Non-Current Assets 565.4m
Current Liabilities 917.7m
Accounts Payable 85.5m
Accrued Liabilities 816.1m
Other Current Liabilities 16m
Non-Current Liabilities 3.1B
Long-Term Debt 2.5B
Other Non-Current Liabilities 528.6m

Balance Sheet
Horizon Therapeutics PLC

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
81
219
860
509
751
959
1 076
2 080
1 580
2 353
Cash Equivalents
81
219
860
509
751
959
1 076
2 080
1 580
2 353
Total Receivables
16
74
210
306
405
465
409
660
633
676
Accounts Receivables
16
74
210
306
405
465
409
660
633
676
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
10
21
23
185
73
55
54
75
226
170
Other Current Assets
4
11
13
47
39
67
147
256
361
454
Total Current Assets
111
325
1 106
1 046
1 268
1 546
1 686
3 070
2 800
3 653
PP&E Net
4
7
14
24
20
20
70
223
368
440
PP&E Gross
4
7
14
24
20
20
70
223
368
440
Accumulated Depreciation
3
4
4
8
14
19
26
48
36
59
Intangible Assets
131
771
1 682
2 773
2 448
1 950
1 703
1 783
3 840
3 475
Goodwill
0
0
254
446
426
414
414
414
1 067
1 011
Other Long-Term Assets
7
12
3
3
40
12
564
582
603
536
Other Assets
0
0
254
446
426
414
414
414
1 067
1 011
Total Assets
253
N/A
1 114
+341%
3 059
+174%
4 292
+40%
4 202
-2%
3 942
-6%
4 436
+13%
6 073
+37%
8 678
+43%
9 115
+5%
Liabilities
Accounts Payable
10
21
17
53
35
30
22
38
30
156
Accrued Liabilities
32
148
336
542
743
674
692
822
819
777
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
48
4
8
11
0
0
0
16
16
Other Current Liabilities
1
1
1
3
7
5
10
16
21
0
Total Current Liabilities
43
219
358
606
795
709
723
876
887
949
Long-Term Debt
111
297
1 133
1 800
1 891
1 897
1 353
1 003
2 555
2 547
Deferred Income Tax
3
0
113
297
158
108
94
67
390
342
Other Liabilities
144
58
142
326
357
39
80
102
173
204
Total Liabilities
302
N/A
574
+90%
1 745
+204%
3 028
+74%
3 201
+6%
2 752
-14%
2 251
-18%
2 047
-9%
4 005
+96%
4 042
+1%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
457
721
681
848
1 242
1 179
606
216
319
590
Additional Paid In Capital
410
1 270
2 002
2 120
2 249
2 375
2 798
4 246
4 373
4 474
Treasury Stock
0
5
5
5
5
5
5
5
5
5
Other Equity
2
4
3
3
1
2
2
0
15
13
Total Equity
49
N/A
540
N/A
1 313
+143%
1 264
-4%
1 001
-21%
1 190
+19%
2 185
+84%
4 025
+84%
4 672
+16%
5 072
+9%
Total Liabilities & Equity
253
N/A
1 114
+341%
3 059
+174%
4 292
+40%
4 202
-2%
3 942
-6%
4 436
+13%
6 073
+37%
8 678
+43%
9 115
+5%
Shares Outstanding
Common Shares Outstanding
66
124
160
162
164
169
188
221
227
227

See Also

Summary
HZNP intrinsic value, competitors valuation, and company profile.
DCF Valuation
HZNP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HZNP stock valuation using valuation multiples.
Wall Street Estimates
HZNP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HZNP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.